» Articles » PMID: 14699069

Interaction with Smad4 is Indispensable for Suppression of BMP Signaling by C-Ski

Overview
Journal Mol Biol Cell
Date 2003 Dec 31
PMID 14699069
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

c-Ski is a transcriptional corepressor that interacts strongly with Smad2, Smad3, and Smad4 but only weakly with Smad1 and Smad5. Through binding to Smad proteins, c-Ski suppresses signaling of transforming growth factor-beta (TGF-beta) as well as bone morphogenetic proteins (BMPs). In the present study, we found that a mutant of c-Ski, termed c-Ski (ARPG) inhibited TGF-beta/activin signaling but not BMP signaling. Selectivity was confirmed in luciferase reporter assays and by determination of cellular responses in mammalian cells (BMP-induced osteoblastic differentiation of C2C12 cells and TGF-beta-induced epithelial-to-mesenchymal transdifferentiation of NMuMG cells) and Xenopus embryos. The ARPG mutant recruited histone deacetylases 1 (HDAC1) to the Smad3-Smad4 complex but not to the Smad1/5-Smad4 complex. c-Ski (ARPG) was unable to interact with Smad4, and the selective loss of suppression of BMP signaling by c-Ski (ARPG) was attributed to the lack of Smad4 binding. We also found that c-Ski interacted with Smad3 or Smad4 without disrupting Smad3-Smad4 heteromer formation. c-Ski (ARPG) would be useful for selectively suppressing TGF-beta/activin signaling.

Citing Articles

Repression of SMAD3 by STAT3 and c-Ski induces conventional dendritic cell differentiation.

Yoon J, Bae E, Nagafuchi Y, Sudo K, Han J, Park S Life Sci Alliance. 2024; 7(9).

PMID: 38960622 PMC: 11222659. DOI: 10.26508/lsa.201900581.


A novel negative regulatory mechanism of Smurf2 in BMP/Smad signaling in bone.

Kushioka J, Kaito T, Okada R, Ishiguro H, Bal Z, Kodama J Bone Res. 2020; 8(1):41.

PMID: 33298874 PMC: 7680794. DOI: 10.1038/s41413-020-00115-z.


Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression.

Oh K, Gottschalk R, Lounsbury N, Sun J, Dorrington M, Baek S J Immunol. 2018; 201(2):757-771.

PMID: 29898962 PMC: 6069956. DOI: 10.4049/jimmunol.1800158.


The role of TGF-β/SMAD4 signaling in cancer.

Zhao M, Mishra L, Deng C Int J Biol Sci. 2018; 14(2):111-123.

PMID: 29483830 PMC: 5821033. DOI: 10.7150/ijbs.23230.


Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate.

Wang W, Song B, Anbarchian T, Shirazyan A, Sadik J, Lyons K PLoS Genet. 2016; 12(10):e1006352.

PMID: 27741240 PMC: 5065210. DOI: 10.1371/journal.pgen.1006352.


References
1.
Sun Y, Liu X, Eaton E, Lane W, Lodish H, Weinberg R . Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell. 1999; 4(4):499-509. DOI: 10.1016/s1097-2765(00)80201-4. View

2.
Nomura N, Sasamoto S, Ishii S, Date T, Matsui M, Ishizaki R . Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res. 1989; 17(14):5489-500. PMC: 318172. DOI: 10.1093/nar/17.14.5489. View

3.
Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K . c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem. 1999; 274(49):35269-77. DOI: 10.1074/jbc.274.49.35269. View

4.
Piek E, Moustakas A, Kurisaki A, Heldin C, Ten Dijke P . TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci. 1999; 112 ( Pt 24):4557-68. DOI: 10.1242/jcs.112.24.4557. View

5.
Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K . Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem. 2000; 275(9):6075-9. DOI: 10.1074/jbc.275.9.6075. View